Bad Drug List
Home / Bad Drugs / Posicor

Posicor

Roche Laboratories manufactured Posicor that was intended as a hypertension and chronic stable angina pectoris medication. In 1997, Posicor manufacturer sent out a "Dear Doctor" letter to inform physicians prescribing Posicor of the new warning information regarding suppression of sinoatrial activity and severe bradycardia and a warning and contraindication concerning drug interactions and statin-induced rhabdomyolysis with Posicor and certain HMG-CoA reductase inhibitors.

On June 8, 1998, Roche Laboratories announced they were withdrawing Posicor from the market due to the drug's risk of serious interactions. When Posicor was combined with certain medications it increased the risk of serious side effects. Roche Laboratories was unable to adequately implement prescribing information that would make the prescribing information clear to patients to avoid serious risk.

There were at least 143 deaths as a result of individuals taking Posicor with the majority of deaths due to heart arrhythmias. If you would like more information on Posicor, please contact us.

MedLine Plus Drug Information - Guide to prescription and over-the-counter medications provided by the United States Pharmacopeia.